Myriad Genetics to Report Fiscal 2010 Fourth Quarter and Year-End Financial Results on August 10

July 20, 2010 at 4:05 PM EDT

SALT LAKE CITY, Jul 20, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will release its fiscal 2010 fourth quarter and year-end financial results at the close of market on Tuesday, August 10, 2010.

The Company will host a conference call on Tuesday, August 10, at 4:30 p.m. Eastern to review the financial results. Participating on the call will be: Peter D. Meldrum, President and Chief Executive Officer; Jim Evans, Chief Financial Officer; Mark C. Capone, President of Myriad Genetic Laboratories, Inc.; and Gary King, Executive Vice President, International Operations.

To participate on the call, callers may dial (800) 786-0540 or (212) 231-2914 approximately 10-15 minutes before the start of the call. All callers will be asked to reference reservation number 21475370.

The conference call also will be available to interested parties through a live audio Internet broadcast at

A replay of the call will be available beginning two hours after the end of the call until seven days following the call and may be accessed by dialing (800) 633-8284 or (402) 977-9140, and entering the reservation number 21475370.

Myriad Genetics, Inc. is a leading molecular diagnostic company focused on developing and marketing novel predictive medicine, personalized medicine and prognostic medicine products. Myriad's news and other information are available on the Company's Web site at

The Myriad Genetics, Inc. logo is available at


This news release was distributed by GlobeNewswire,

SOURCE: Myriad Genetics, Inc.

CONTACT: Myriad Genetics
Suzanne Barton, Director, Investor Relations
(801) 584-1138

(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.

News Provided by COMTEX